RP Cure Tracker

Trials / NCT06306690

Biomarkers in Retinitis Pigmentosa

Status unknown Observational Natural history / observational

Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Treatment
OCT, OCT angiography, flicker ERG and Ultra Wide Field retinography and autofluorescence.
Gene
Not stated
Conditions
Retinitis Pigmentosa
Ages
18 Years to no upper limit
Enrollment
35 participants
Started
2024-02-01
Main results expected
2025-04
Results posted
Not yet
Record last updated
2024-03-12

What the study is testing

The objective of this study is to discover biomarkers that demonstrate a correlation between the severity of retinitis pigmentosa (RP) and the thickness of the retinal pigment epithelium (RPE). These biomarkers will serve as prognostic indicators for various kinds of retinitis pigmentosa. The objective of this study is to find biomarkers that establish a correlation between the severity of retinitis pigmentosa and the thickness of the retinal pigment epithelium (RPE), which can serve as a prognostic indicator for Retinitis Pigmentosa.

Where it runs

Italy (1)

Open on ClinicalTrials.gov for contacts and eligibility